If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michele Spina is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Non-Hodgkin's Lymphoma Medicine & Life Sciences
HIV Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, Spina, M., Ladetto, M. & Merli, F., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
Radiotherapy

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, Spina, M., Ladetto, M. & Merli, F., Dec 2019, In : Leukemia and Lymphoma. 60, 12, p. 2890-2898 9 p.

Research output: Contribution to journalArticle

Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
Radiotherapy

Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study

Rigacci, L., Puccini, B., Broccoli, A., Dona, M., Gotti, M., Evangelista, A., Santoro, A., Bonfichi, M., Re, A., Spina, M., Botto, B., Pulsoni, A., Pagani, C., Stelitano, C., Salvi, F., Nassi, L., Mannelli, L., Kovalchuk, S., Gioia, D. & Zinzani, P. L., Jan 1 2019, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Positron-Emission Tomography
Hodgkin Disease
Salvage Therapy
Therapeutics
Secondary Prevention

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Luminari, S., Merli, M., Rattotti, S., Tarantino, V., Marcheselli, L., Cavallo, F., Varettoni, M., Bianchi, B., Merli, F., Tedeschi, A., Cabras, G., Re, F., Visco, C., Torresan Delamain, M., Cencini, E., Spina, M., Ferrero, S., Ferrari, A., Deodato, M., Mannina, D. & 7 others, Annibali, O., Rago, A., Orsucci, L., Defrancesco, I., Frigeni, M., Cesaretti, M. & Arcaini, L., Sep 5 2019, In : Blood. 134, 10, p. 798-801 4 p.

Research output: Contribution to journalArticle

Disease Progression
Lymphoma
Survival
B-Cell Lymphoma
Follicular Lymphoma

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Luminari, S., Merli, M., Rattotti, S., Tarantino, V., Marcheselli, L., Cavallo, F., Varettoni, M., Bianchi, B., Merli, F., Tedeschi, A., Cabras, G., Re, F., Visco, C., Torresan Delamain, M., Cencini, E., Spina, M., Ferrero, S., Ferrari, A., Deodato, M., Mannina, D. & 7 others, Annibali, O., Rago, A., Orsucci, L., Defrancesco, I., Frigeni, M., Cesaretti, M. & Arcaini, L., Sep 5 2019, In : Blood. 134, 10, p. 798-801 4 p.

Research output: Contribution to journalArticle

Disease Progression
Lymphoma
Survival
B-Cell Lymphoma
Follicular Lymphoma